Recent studies have indicated that 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to the fall in cerebral blood flow (CBF) following subarachnoid hemorrhage (SAH) but the factors that stimulate the production of 20-HETE are unknown. This study examines the role of vasoactive factors released by clotting blood versus the scavenging of NO by hemoglobin (Hb) in the fall in CBF following SAH. Intracisternal (icv) injection of blood produced a greater and more prolonged (120 versus 30 min) decrease in CBF than that produced by a 4% solution of Hb. Pretreated of rats with L-NAME (10 mg/kg, i.v.) to block the synthesis of NO had no effect on the fall in CBF produce by an icv injection of blood. L-NAME enhanced rats than attenuated the fall in CBF produced by an icv injection of Hb. Blockade of the synthesis of 20-HETE with TS-011 (0.1 mg/kg, i.v.) prevented the sustained fall in CBF produced by an icv injection of blood and the transient vasoconstrictor response to Hb. Hb (0.1%) reduced the diameter of the basilar artery (BA) of rats in vitro by 10 ± 2%. This response was reversed by TS-011 (100 nM). Pretreatment of vessels with L-NAME (300 µM) reduced the diameter of BA and blocked the subsequent vasoconstrictor response to addition of Hb to the bath. TS-011 returned the diameter of vessels exposed to L-NAME and Hb to control. These results suggest that the fall in CBF following SAH is largely due the release of vasoactive factors by clotting blood rather than the scavenging of NO by Hb and that 20-HETE contributes the vasoconstrictor response of cerebral vessels to both Hb and blood.
Introduction
Cerebral vasospasm is a critical complication of subarachnoid hemorrhage (SAH).
Vasospasm occurs in 70% of patients with aneurysmal SAH and leads to ischemic deficits in 36% of patients (5) . Despite extensive investigation the factors that trigger the fall in cerebral blood flow (CBF) following SAH remain to be determined.
The fall in CBF following SAH correlates with the amount of hemoglobin (Hb) released into cerebrospinal fluid (CSF) and vasospasm can be triggered by an injection of Hb alone into the CSF (31, 51) . Hb induces hemeoxygenase-1 (HO-1) (24) that increases iron levels which generate superoxide radicals (30). Superoxide radicals at low concentration have been reported to constrict vessels in several vascular beds in part by decreasing the levels of nitric oxide (NO) (13, 42), and there is a recent report that supports a similar mechanism in cerebral arteries (55). Free radicals also increase the production of lipid peroxides and isoprostanes (20, 44) that are potent constrictors of cerebral arteries (19).
Previous studies have focused on the role of various vasoconstrictor pathways in the development of cerebral vasospasm. The levels of endothelin (46) , thromboxane (36) , ATP (31), isoprostanes (44), glutamate (4), platelet-activating factor (PAF) (17) and serotonin (5-HT) (6, 43) in CSF all increase following SAH and the response of cerebral arteries to most of these constrictors are enhanced. Cerebral vasospasm following SAH has been reported to be attenuated by inhibitors of endothelin synthesis or receptors (10, 12), 5-HT receptor antagonists (6) and by inhibitors of the downstream effectors of these vasoconstrictors, including Ras, Rho, mitogen-activated protein kinase (MAPK) and protein kinase C (PKC) (25, 26, 33, 52) . There is also enhanced release of fatty acids (37) following SAH that increases the formation of vasoactive metabolites of arachidonic acid (AA) Recent studies have revealed that the concentration of 20-HETE increases in the CSF of rats (6, 22) , dogs (14) and patients (15, 38) following SAH and that inhibitors of the synthesis of 20-HETE or its vasoconstrictor actions prevent the acute fall in CBF following SAH in rats (6, 22, 23, 33) and reverse delayed vasospasm in both dogs (14) and rats (49) . However, the factors released by clotting blood that stimulate the release of 20-HETE in CSF following SAH, and the mechanisms by which 20-HETE interacts with the other constricting factors to contribute to the fall in CBF following SAH are unknown. Thus, the present study examined the relative importance of the release of vasoactive factors by clotting blood versus scavenging of NO by Hb in triggering the fall in CBF following SAH. We also examined the effects of blocking the synthesis of NO with N ω -nitro-L-arginine methyl ester (L-NAME) and 20-HETE with TS-011 on the fall in CBF produced by injections of blood and Hb into the cisterna magna of rats in vivo and on the vasoconstrictor response of rat basilar arteries to Hb in vitro.
Materials and Methods
General. Experiments were performed on male Sprague-Dawley rats purchased from Taconic Farms (Germantown, NY) that weighed 250-350 g. The rats were housed in an AAALAC-approved Animal Care Facility at the Medical College of Wisconsin and they had free access to food and water. All protocols were approved by the Animal Care Committee of the Medical College of Wisconsin.
Induction of SAH and measurement of cerebral blood flow. Rats were surgically prepared for induction of SAH and measurement of CBF using laser Doppler flowmetry (Perimed, Stockholm, Sweden) as previously described (6, 22) . Briefly, the rats were anesthetized with isoflurane (2.0%) and the left femoral artery and vein were cannulated for measurement of arterial pressure and for the infusion of drugs. Body temperature was maintained at 37º C with a heating pad. The rats were positioned in a stereotaxic device and a 3x3 mm area of left parietal bone overlying the irrigation area of the middle cerebral artery (MCA) was thinned with hand-held drill until the pial vessels were visible. A laser Doppler probe was placed above the cranial window for measurement of regional CBF. The atlanto-occipital membrane was exposed and 30-gauge needle attached to a PE-10 catheter was inserted into the cisterna magna for withdrawal of cerebrospinal Statistical Analysis. Mean values ± S.E. are presented. The significance of differences in mean values between and within groups was evaluated using an ANOVA for repeated measures followed by Holm-Sidak test. A P < 0.05 was considered to be significant.
Results

Protocol 1: Comparison of the effects of icv injections of blood and Hb on CBF. The results
of these experiments are presented in Fig. 1 . An icv injection of saline had no effect on CBF. CBF fell to 51.1 ± 9.6% of control after an icv injection of blood and it remained 30% below control for the entire 2 hr course of the experiment. CBF fell to 63.5 ± 7.2% of control immediately after an icv administration of Hb. However, the response was transient and returned to levels not significantly different from control within 1 hr.
Protocol 2: Effects of blockade of NO on the fall in CBF following an icv injection of blood
or Hb. Pretreatment of the rats with L-NAME reduced baseline CBF by 15% (Fig. 2) . However, CBF still fell by an additional 22% after an icv administration of blood. The fall in CBF in rats pretreated with L-NAME was of the same magnitude and duration as the response seen in control rats. CBF fell by 28% immediately following an icv injection of Hb in rats pretreated with L-NAME. The magnitude of the fall in CBF following administration of Hb tended to be slightly, but not significantly greater in rats treated with L-NAME than that seen in the control rats and the duration of the response was more prolonged (120 versus 30 minutes) .
Protocol 3: Effects of TS-011 on the fall in CBF following an icv injection of blood or Hb.
The effects of TS-011, a selective inhibitor of the synthesis of 20-HETE (31), on the fall in CBF induced by an icv injection of blood or Hb are presented in Fig. 3 . Blockade of the synthesis of 20-HETE had no significant effect on baseline CBF. TS-011 had no effect on the immediate fall in (Fig 4A) . Pretreatment of the vessels with L-NAME (300 µM) to block the synthesis of NO, reduced the control diameter of the BA by 18.5 ± 2.1 µm and blocked the subsequent response to Hb (0.1%). TS-011 (100 nM) fully reversed the vasoconstriction and returned the diameter of these vessels to control (Fig 4B) . In contrast, blockade of the synthesis of NO with L-NAME had no effect on either the magnitude or duration of the fall in CBF produced by an icv injection of blood. This finding suggests that factors other than scavenging of NO contribute to the fall in CBF following the icv injection of blood and SAH. It is likely that the release of vasoconstrictor mediators by clotting blood plays a major role in triggering the fall in CBF following SAH. This conclusion is further supported by previous findings that the levels of endothelin (46) suggest that the vasoconstrictor response of the cerebral arteries to Hb in vitro, which appeared to be largely mediated by scavenging of NO since it was completely blocked by L-NAME, is dependent on the formation of 20-HETE. This finding does not fit with the generally accepted view that the vasodilator response to NO is secondary to activation of soluble guanylate cyclase and elevations in cyclic guanosine monophosphate (cGMP) (28). However, we and others have reported that NO directly binds to heme in CYP4A enzymes and inhibits the formation of 20-HETE (47) . We have also shown that NO induced activation of the K Ca channels in rat renal interlobular arteries and in the middle cerebral artery of the rat is cGMP-independent and is associated with inhibition of the endogenous formation of 20-HETE in VSM cells (47, 48) . Further studies have shown that inhibitors of the synthesis of 20-HETE reduce the vasodilator response to NO in renal and cerebral arteries by 50 to 75% (1, 3) and the pressor response of rats to blockade of NO synthesis with L-NAME in vivo (17). Thus, the present data suggest that the in part to an increase in 20-HETE production in cerebral arteries which blocks K Ca channels and depolarizes VSM cells. Moreover, these findings suggest that the success of recent therapeutic strategies using NO donors and NOS gene therapy for the treatment of cerebral vasospasm (38, 45) will likely depend on the levels of expression of CYP4A enzymes in cerebral arteries and elevated levels of 20-HETE.
Discussion
Perspectives
The results of the present study indicate that the fall in CBF following SAH is largely due the 
